You get one six-month window to buy any Medigap policy without a health exam, and missing it can lock you out later

Image Credit: Unknown author/

The most valuable window in a retiree’s Medicare life lasts six months, opens only once, and then closes for good, yet most people never hear about it until it has already passed. During that stretch, any insurer selling Medicare supplement coverage in a person’s state must offer its full lineup at its best price, ask no health questions, and charge no extra for a pre-existing condition. Once it lapses, that same policy can be denied outright or priced far out of reach.

The one-time window that opens at 65

The period is called Medigap Open Enrollment, and its timing is fixed by federal law rather than by any insurer. It begins on the first day of the month a person is both 65 or older and enrolled in Medicare Part B, and it runs for six consecutive months. Medicare’s guidance on when to buy a Medigap policy spells out the protection: during the window an insurance company cannot refuse to sell any policy it offers, cannot make an applicant wait for coverage to begin, and cannot use medical underwriting to raise the premium or reject the application over past or current health problems. It is the single stretch when a healthy applicant and a seriously ill one can buy the identical plan at the identical rate.


Free retirement updates: One number can cost or save hundreds a month in retirement. The free Retirement Shield newsletter surfaces the ones worth knowing. Sign up free.

What guaranteed issue is actually worth

The value of that protection becomes clear only when it is gone. Outside the window, insurers in most states may run a full health review, and someone with diabetes, heart disease, or a cancer history can be quoted a sharply higher premium or turned down altogether. Because Original Medicare places no annual limit on a beneficiary’s twenty percent share of costs, a supplement is the main tool that caps that exposure, and locking one in during the guaranteed-issue window secures the standard rate for life. A person who waits and later develops a health problem may find the exact policy that would have cost a modest monthly premium at 65 is now unavailable at any price, leaving a coverage gap precisely when medical bills are most likely to mount.

Why the window does not come back

A common and expensive mistake is confusing this one-time window with the annual Medicare Open Enrollment period that runs each October 15 to December 7. That yearly window governs Medicare Advantage and Part D drug plans and repeats every fall, but the Medigap Open Enrollment Period does not repeat at all. It is triggered by Part B enrollment, which means a person who delays Part B because they are still working and covered by an employer plan also delays the start of the Medigap window until the month Part B actually begins. For most people it arrives once, tied to that Part B start date, and never returns on its own terms.

The narrow second chances the law provides

Federal rules do carve out a set of guaranteed-issue rights outside the original window, but they are situational and time-limited. As the Medigap basics guidance describes, these protections can apply when a Medicare Advantage plan leaves the area or a member moves out of its service region, when other coverage such as an employer or union plan ends, when an insurer goes bankrupt or misleads the enrollee, or during a trial period for someone who tried Medicare Advantage at 65 and wants to return to Original Medicare within the first year. In those cases an applicant generally has 63 days to secure a supplement without underwriting, but only certain plan types qualify, and the burden falls on the beneficiary to act inside the deadline.

Switching supplements after the window closes

Once the six months end and no special right applies, changing a Medigap policy usually means submitting to medical underwriting, and an insurer is then free to reject an applicant or charge more based on health. A handful of states soften this: some require insurers to offer coverage on a continuous or annual guaranteed-issue basis, and several have adopted “birthday rules” that let a beneficiary switch to an equal or lesser plan each year without a health review. Those exceptions are the minority, and they vary widely in their fine print. For most retirees across most of the country, the safe assumption is that the guaranteed-issue six months are the only clean shot at a supplement, which is why Medicare urges enrollees to treat the window as a deadline rather than an option to revisit later.

Why the pricing method matters as much as the timing

Buying during the window secures the policy, but how an insurer prices that policy shapes what it costs for the rest of a beneficiary’s life, and the two decisions deserve equal weight. Medigap plans are generally priced one of three ways. A community-rated policy charges the same premium regardless of age, so a person who buys at 65 and one who buys at 80 pay the same base rate. An issue-age policy sets the premium based on age at purchase and does not raise it simply because the holder grows older, which rewards buying earlier. An attained-age policy starts lower but climbs as the holder ages, so a plan that looks cheap at 65 can become the most expensive option two decades later. All three can still rise with general inflation, but the underlying method determines how steeply the cost grows over time. Because the guaranteed-issue window is also usually the point at which a person is youngest and healthiest as a Medicare beneficiary, it is where issue-age and community-rated pricing lock in their biggest long-term advantage. Comparing not just the plan letter and the first-year premium but the pricing method behind each quote is what separates a supplement that stays affordable from one that quietly outgrows a fixed income, which is why asking every insurer which method it uses belongs on the checklist before signing.

This article was produced with the assistance of artificial intelligence and reviewed by The Financial Wire editorial team.

More Financial Reading

Leave a Reply

Your email address will not be published. Required fields are marked *